Direct measurement of muscarinic agents in the central nervous system of mice using ex vivo binding-Reference-Cited by-同舟云学术

Direct measurement of muscarinic agents in the central nervous system of mice using ex vivo binding

Published:1989-12 Issue:2-3 Volume:174 Page:253-260
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Freedman S.B.,Harley E.A.,Patel S.

Publisher

Elsevier BV

Subject

Pharmacology

Reference17 articles.

1. ‘Ex vivo’ binding: A measure of drug penetration in the CNS;Carroll;Br. J. Pharmacol.,1987

2. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction;Cheng;Biochem. Pharmacol.,1973

3. Antagonism of aceclidine-induced tremor, analgesia, hypothermia, salivation and lacrimation by some pharmacologic agents;Chiang;Arch. Int. Pharmacodyn.,1971

4. Quantitative ‘in vivo’ receptor binding I: Theory and application to the muscarinic cholinergic receptor;Frey;J. Neurosci.,1985

5. Relative affinities of drugs at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors;Freedman;Br. J. Pharmacol.,1988

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing the Access of Cholinergic Antagonists to Efferent Synapses in the Inner Ear;Frontiers in Neuroscience;2021-12-14

2. Central muscarinic and LPBN mechanisms on sodium intake;Brain Research Bulletin;2019-01

3. Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M 1 , M 2 , and M 4 receptor knockout mice;Behavioural Brain Research;2017-06

4. Central mechanisms involved in pilocarpine-induced pressor response;Autonomic Neuroscience;2011-10

5. A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder;British Journal of Clinical Pharmacology;2011-07-11